Cambridge scientists develop repurposed liver drug to combat Covid-19
An off-patent drug used to treat lung disease has been identified by scientists at the University of Cambridge as a potential medicine to fight the.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
An off-patent drug used to treat lung disease has been identified by scientists at the University of Cambridge as a potential medicine to fight the.